get the top three things to know in women's health + wellness, every weekday:

Fixing America’s Maternal Mental Health Shame

What: The Biden administration’s Maternal Mental Health task force released national recommendations that aim to improve the mental health of new moms. In the United States, nearly a quarter of all pregnancy-related deaths are due to mental health conditions, including substance use disorders. One of the main recommendations is bringing mental health care into “all relevant perinatal settings, such as obstetricians’ offices, primary care offices, pediatric outpatient settings, emergency rooms, inpatient settings (including medical units), labor and delivery settings, postpartum units, and neonatal intensive care units.”

Why it matters: This report was requested by Congress and could serve as the foundation for legislation that puts the might of the federal government and its spending power behind efforts to improve maternal mental health.

SourceHHS

More News Snippets
The Birth Rate Fallacy

Experts explaining that the global drop in fertility rates is partly a product of women having children later in life.

Alcohol’s Lies (and Breast Cancer)

A deep dive on drinking and examining why people reacted far more swiftly to the news that smoking causes cancer than they have for alcohol—especially breast cancer.

OBGYN Pain Goes Beyond IUDs

Sharing the stories of women who have had fibroids removed without pain medication or endometriosis symptoms ignored for years.

To Prevent the Cancer from Returning

An essay from Rachel Manteuffel on her breast cancer diagnosis and treatment that manages to be funny while also tackling the wrenching choice to have chemotherapy or not after a mastectomy.

Another Mother Dead Thanks to Abortion Bans

Josseli Barnica was excited to be pregnant with her second child but suffered a miscarriage at 17 weeks. Instead of helping the miscarriage progress, doctors let her suffer for 40 hours because her fetus still had a heartbeat.

Could Ozempic Prevent Fibroids?

Women with type 2 diabetes who got a GLP-1 medication were less likely to develop new fibroids than women who just took metformin, a diabetes medication.